HighRes® and Waters Collaborate to Advance Drug Discovery through Robotic Automation
AI Briefing
- • HighRes and Waters collaborate on robotic automation for flow cytometers in drug discovery research.
- • Integration enables automation of experimental steps and streamlines research workflows.
- • BD FACSLyric flow cytometer paired with HighRes Automation and Cellario Software Platforms.
Source Summary
BEVERLY, Mass.--(BUSINESS WIRE)--HighRes® today announced a strategic collaboration to enable robotic capabilities on Waters Biosciences, formerly BD Biosciences, flow cytometers to automate key experimental steps and streamline research workflows, from basic research to drug discovery. The companies are integrating the BD FACSLyricTM Flow Cytometer1 with the HighRes Nucleus® Automation and Cellario® Software Platforms, enabling scientists to utilize robotic arm capabilities to run reliable, com
Advertisement